Latest Regulatory News

(E,E)-bisantrene, Race Oncology’s lead anticancer candidate, operates by binding to G4-DNA and RNA structures, revealing a novel mechanism that disrupts key cancer drivers including the MYC gene.

DGR Global Limited will have its trading suspension lifted on 2 October 2025 following the lodgement of its annual report, marking a key step back to market normalcy.

Audalia Resources has completed a $500,000 placement to a sophisticated investor, issuing 20 million shares to fund critical development stages at its Medcalf Project. The capital injection aims to advance mining design, permits, and approvals while bolstering working capital.

Critical Resources Limited has initiated its first Reverse Circulation drilling program at the Amoco gold-antimony project in New South Wales, targeting a significant geochemical anomaly with promising high-grade surface samples. The results, expected by mid-November 2025, could unlock new value in a historically mineralized region.

Finder Energy is fast-tracking development of the Kuda Tasi and Jahal oil fields in Timor-Leste, backed by a transformational farmin deal with TIMOR GAP and a strategic alliance with SLB, targeting first oil by October 2025.

Cryosite Limited has inked a deal to acquire a strategic freehold warehouse in Auburn, NSW, doubling its storage capacity and positioning itself for significant growth in clinical trial logistics.

Gold Mountain Limited has voluntarily suspended trading on the ASX pending an announcement that will update the issue price of a recent capital raising placement.

International Graphite Limited has attracted a significant institutional investment of up to $3 million from Pioneer Resource Partners to fund key development stages of its Springdale Graphite Project and processing operations.

Podium Minerals has announced a major metallurgical breakthrough with a new concentrator flowsheet achieving approximately 80% recovery of key platinum group metals, advancing its Parks Reef Project towards commercialisation.

Flynn Gold Limited’s FG1OA securities have been suspended from trading due to non-compliance with ASX listing rules, raising questions about the company’s regulatory standing.

CONNEQT Health has raised $2 million through a convertible note facility with a director-owned entity, providing fresh capital to support its growth plans. Shareholder approval will be key to unlocking the full benefits of this funding.

Vanguard Investments Australia has announced estimated distribution amounts and a clear timetable for over 20 of its Australian-listed ETFs, with payments scheduled for mid-October 2025.